|Back to main|
1/25/2011 2:24:05 PM
Healthcare giant Johnson & Johnson ( JNJ ) on Tuesday said its fourth quarter profit was mostly flat from last year, matching analyst estimates, but revenue fell short of expectations.
The New Brunswick, NJ-based company reported fourth quarter net income of $2.86 billion, or $1.03 per share, compared with $2.85 billion, or $1.02 per share, in the year-ago period.
Revenue fell more than 5% from last year to $15.64 billion.
On average, Wall Street analysts expected a matching profit of $1.03 per share, albeit on higher revenue of $16.02 billion.
Johnson & Johnson shares fell $1.54, or -2.5%, in premarket trading Tuesday.
The Bottom Line
Johnson & Johnson ( JNJ ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.